TYRX to exhibit AIGISRx Anti-Bacterial Envelope at HFSA

Download PDF Copy

Sep 14 2009

NewsGuard 100/100 Score

TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, announced today that it will be exhibiting its lead product, AIGISRx™ Anti-Bacterial Envelope, at the 13th Annual Heart Failure Society of America Meeting (HFSA), in Boston, MA this week.

The Heart Failure Society of America, Inc. (HFSA) brings together heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care.

AIGISRx is an anti-bacterial mesh envelope developed to deliver anti-microbial agents that help provide protection against infections associated with implanted pacemakers and cardioverter defibrillators. AIGISRx also securely holds a pacemaker (PM) or implantable cardioverter defibrillator (ICD) in order to create a stable environment when implanted in the body.

SOURCE: TYRX, Inc.

Posted in: Device / Technology News

Tags: Cancer, Cardiology, Congestive Heart Failure, Defibrillator, Endocarditis, Heart, Heart Failure, Pacemaker, Pharmaceuticals, Research

Comments (0)

Download PDF Copy

Suggested Reading

CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis

CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis

Tirzepatide improves heart health and function in obese HFpEF patients

Tirzepatide improves heart health and function in obese HFpEF patients

New nasal spray form of bumetanide shows promise for heart failure treatment

New nasal spray form of bumetanide shows promise for heart failure treatment

Decoding the genetic roots of stroke and heart attack

Decoding the genetic roots of stroke and heart attack

Electronic nudges boost flu vaccination rates among heart attack survivors

Electronic nudges boost flu vaccination rates among heart attack survivors

Ablation may offer better outcomes than medication for ventricular tachycardia

Ablation may offer better outcomes than medication for ventricular tachycardia

Hypertension drug may reduce heart failure risk in people recovering from heart attack

Hypertension drug may reduce heart failure risk in people recovering from heart attack

Coronary artery calcium scores found to predict risk of heart attack and death in both men and women

Coronary artery calcium scores found to predict risk of heart attack and death in both men and women

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Study reveals variability in polygenic risk scores for predicting heart disease